Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
G Meyer, S Konstantinides - European Respiratory Journal, 2020 - Eur Respiratory Soc
We would like to thank H. Slabbynck and co-workers for their interest in the 2019 European
Society of Cardiology/European Respiratory Society guidelines on the diagnosis and …
Society of Cardiology/European Respiratory Society guidelines on the diagnosis and …
[引用][C] Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk …
G Meyer, S Konstantinides - The European Respiratory Journal, 2020 - europepmc.org
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk
pulmonary embolism secondary to a major transient/reversible risk factor? - Abstract - Europe …
pulmonary embolism secondary to a major transient/reversible risk factor? - Abstract - Europe …
[引用][C] Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk …
G Meyer, S Konstantinides - The European respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk
pulmonary embolism secondary to a major transient/reversible risk factor? Should oral …
pulmonary embolism secondary to a major transient/reversible risk factor? Should oral …
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
H Slabbynck, J Clukers… - European Respiratory …, 2020 - Eur Respiratory Soc
Important recommendations for the regimen and duration of anticoagulation after pulmonary
embolism (PE) are proposed in the new/revised concepts in the 2019 European Society of …
embolism (PE) are proposed in the new/revised concepts in the 2019 European Society of …
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
H Slabbynck, J Clukers, D Galdermans - European Respiratory Journal, 2020 - qdcxjkg.com
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk
pulmonary embolism secondary to a Page 1 Should oral anticoagulation be discontinued after 3 …
pulmonary embolism secondary to a Page 1 Should oral anticoagulation be discontinued after 3 …
[引用][C] Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk …
H Slabbynck, J Clukers… - The European …, 2020 - pubmed.ncbi.nlm.nih.gov
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk
pulmonary embolism secondary to a major transient/reversible risk factor? Should oral …
pulmonary embolism secondary to a major transient/reversible risk factor? Should oral …
[引用][C] Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk …
H Slabbynck, J Clukers… - The European Respiratory …, 2020 - europepmc.org
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk
pulmonary embolism secondary to a major transient/reversible risk factor? - Abstract - Europe …
pulmonary embolism secondary to a major transient/reversible risk factor? - Abstract - Europe …